Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591828 | SCV000706723 | uncertain significance | not provided | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088435 | SCV001009706 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2023-08-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456307 | SCV002737577 | likely benign | Cardiovascular phenotype | 2018-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |